We've found
184,457
clinical trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Tailored Antiplatelet Therapy Following PCI
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Neurology, Psychiatry / Psychology, Other Clinical Trial
Prospective Research in Infants With Mild Encephalopathy
Status: Enrolling
Updated: 9/21/2015
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status: Enrolling,
Phase
I
Updated: 11/9/2015
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Liraglutide In Overweight Patients With Type 1 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/2/2017
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
A Multi-Center Trial to Study Acute Liver Failure in Adults
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Angina Pectoris Clinical Trial
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
Status: Enrolling,
Phase
III
Updated: 11/16/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Low Risk Prostate Cancer Clinical Trial
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Tailored Antiplatelet Therapy Following PCI
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Neurology, Psychiatry / Psychology, Other Clinical Trial
Updated: 9/21/2015
Prospective Research in Infants With Mild Encephalopathy
Status: Enrolling
Updated: 9/21/2015
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Updated: 11/9/2015
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status: Enrolling,
Phase
I
Updated: 11/9/2015
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Updated: 11/2/2017
Liraglutide In Overweight Patients With Type 1 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/2/2017
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Updated: 4/8/2013
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Updated: 4/8/2013
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Updated: 12/31/1969
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
Updated: 10/4/2013
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
Updated: 10/4/2013
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
Updated: 10/4/2013
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
Updated: 10/4/2013
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
Updated: 10/4/2013
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
Updated: 12/31/1969
A Multi-Center Trial to Study Acute Liver Failure in Adults
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Angina Pectoris Clinical Trial
Updated: 11/16/2015
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
Status: Enrolling,
Phase
III
Updated: 11/16/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 12/31/1969
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Low Risk Prostate Cancer Clinical Trial
Updated: 12/31/1969
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials